$Cibus Inc (CBUS.US)$
Can Cibus' Gene-Edited Canola Traits Revolutionize Crop Disease Management?

$Cibus Inc (CBUS.US)$
Cibus, Inc. Announces $22.6 Million Registered Direct Offering Priced Above Nasdaq's Minimum Price in Accordance with Nasdaq Rules
Tuesday, 21st January at 8:30 am
SAN DIEGO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ: CBUS) (the "Company" or "Cibus"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced it has entered into securities...

$Cibus Inc (CBUS.US)$
Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus' First Gene Edited Weed Management Solution for U.S. Rice Growers
Monday, 16th December at 7:00 am
Cibus' Rice Herbicide Tolerance (HT-3) Commercialization Efforts Continue Promising Progress to deliver a new Weed Management Solution for Farmers in the U.S.
Cibus and its partners Albaugh and RTDC Continue Their Research and Development Collaboration to Enable Commerciali...

$Cibus Inc (CBUS.US)$
Cibus Achieves Additional Milestone for Next Generation Gene Edits for Sclerotinia Resistance in Canola
Cibus (NASDAQ: CBUS) has successfully completed gene edits in Canola for its 4th mode of action targeting Sclerotinia (White Mold) resistance trait, with greenhouse results expected in Q1 2025. This achievement follows positive field trial results from their 2nd mode of action, which demonstrated enhanced disease resistance. Sclerotinia is identified as the most signif...

$Cibus Inc (CBUS.US)$
Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola

$Cibus Inc (CBUS.US)$will be rocket

$Cibus Inc (CBUS.US)$
Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice
Cibus (Nasdaq: CBUS) has announced positive initial field trial results for a novel weed management solution in rice using stacked gene edited herbicide tolerant traits. The trials showed that using two herbicides provided excellent weed control. This approach could enable farmers to use a comprehensive weed management system with two different modes of action, p...

$Lixte Biotechnology (LIXT.US)$ 700k float / 60% institutional /67% CTB
$Grove Collaborative (GROV.US)$ 16m float / 74% institutional/ 30% CTB
$Acorda Therapeutics (ACOR.US)$ 1.2m float/ 18% institutional/ 37% CTB
$Verastem (VSTM.US)$ 16m float / 40% institutional/ 18% CTB
$Cibus Inc (CBUS.US)$ 16m float / 12% institutional
$Bone Biologics (BBLG.US)$ 27m float / 17% institutional/ 127% CTB
$Greenlane (GNLN.US)$ 1.5m float/ 17% institutional/ 35% CTB
$VistaGen Therapeutics (VTGN.US)$ 7.2m floa...